The "6th Edition of Cardiology World Conference" (Cardio 2025) takes place in London, UK and Virtually, from September 15-17, 2025.
The conference, with its overarching theme of “Advancing Heart Health: Breakthroughs in Cardiology” covers a comprehensive range of topics, including cardiovascular diseases and disorders, advanced imaging techniques such as echocardiography and cardiac MRI, and innovative treatments for heart failure and myocardial infarction.
ESC Congress 2025 together with World Congress of Cardiology
Friday, 29 August - Monday, 01 September 2025
Madrid - Spain
The 2025 ESC Congress is a special edition as it comes together with the World Congress of Cardiology.
The 21st IDDST (Europe), takes place June 18 - 20, 2025 in Stockholm, Sweden, and will host leading scientists from the academia and outstanding international experts from industry worldwide, to discuss the latest developments in drug discovery and therapy. The program will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. Main idea and target is to stimulate new creative ideas to translate new discoveries into better practice and application.
In session IDDST 01, June 18: Breaking Research in Drug Discovery ...
The congress takes place 2025 in Rome, Italy, from June 5 - 7.
The most important aspect of this congress is bridging science, innovation, and patient care with the focus on heart health.
The scientific sessions bring together experts from the fields of basic research, translational medicine, pharma R&D, and patient care in order to help to improve cardiovascular outcomes.
The Cardiology World Conference CARDIO 2024 takes place September 5 - 7, 2024, in Madrid, Spain.
The lecture of Thomas Bernd Dschietzig is about treatment of HFpEF and focuses on pre-clinical experiments and results with relaxin-2, explaining the bolus therapy and the signalling portfolio of the native peptide.
Relaxin-2 delivery reverses diastolic dysfunction, arrhythmia susceptibility, inflammation, and excess fibrosis.
...
The Heart Failure Congress takes place September 28 – 30, 2023, in Göttingen, Germany. The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities. On September 28, the session “Pipeline for the therapy of heart failure” (at 1 pm) [...]
Relaxera is supporting and attending the 9th International Conference on Relaxin and Related Peptides. Featured presenters cover all aspects of basic biology and physiology, plus potential clinical applications of relaxin and related peptides. One of our contributions will be the chairing of the session “Circulatory and Vasculatory Actions". As well we present new research results [...]
Two interviews with the Bavarian Health Management GmbH in Germany about "Relaxin and Heart Failure" and "Relaxin and Transplantation Medicine". Prof. Andreas Grün is interviewing Prof. Dr. Thomas B. Dschietzig, CEO Relaxera. (in German language) interview 1 - Relaxin and heart failure; get the summary here. interview 2 - Relaxin and transplantation medicine; get the [...]
First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session "HFpEF and HFmrEF: what’s new in treatment" - “The therapeutic potential of relaxin for heart failure with preserved ejection fraction” You will learn about relaxin-2-[...]
